PR Newswire
BOULDER, Colo., Nov. 8, 2017
BOULDER, Colo., Nov. 8, 2017 /PRNewswire/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will
present at the 2017 Stifel Healthcare Conference. The public is welcome to participate in the conference through a webcast
on the Array BioPharma website.
|
Event:
|
Stifel Healthcare Conference
|
|
Presenter:
|
Andy Robbins, Chief Operating Officer
|
|
Date:
|
Wednesday, November 15, 2017
|
|
Time:
|
11:00 a.m. Eastern Time
|
|
Webcast:
|
http://wsw.com/webcast/stifel10/arry/
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of
targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing
related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with
AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo
Oncology) and tucatinib (partnered with Cascadian Therapeutics).
View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-stifel-healthcare-conference-300551492.html
SOURCE Array BioPharma